论文部分内容阅读
澳大利亚治疗药品管理局已调研了使用轮状病毒疫苗Rotavix和RotaTeq与发生罕见的肠梗阻,即肠套叠之间的可能联系。首次研究使用了2种监测系统,即儿科强化疾病监测单位和澳大利亚儿科监测单位。此项研究发现婴儿使用疫苗后1周,与肠套叠住院历史资料比,发生肠套叠的危险增加了4倍,即每100 000个疫苗首剂注射后增加2例肠套叠。
The Australian Agency for Drug Control and Treatment has investigated the possible link between the use of Rotavix and the RotaTeq rotavirus in the development of a rare intestinal obstruction known as intussusception. The first study used two monitoring systems, the pediatric intensive disease surveillance unit and the Australian pediatric surveillance unit. The study found a 1-week increase in the frequency of intussusception in infants with a 4-fold increase in the risk of intussusception compared with hospitalized patients with intussusception 1 week after infusing the vaccine, ie, 2 more intussusceptions per 100 000 vaccine dose.